Skip to main content
Gene Kurosawa, MD, Anesthesiology, Boston, MA

GeneKurosawaMD

Anesthesiology Boston, MA

Cardiothoracic Anesthesiology

Physician

Dr. Kurosawa is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Kurosawa's full profile

Already have an account?

  • Office

    330 Brookline Ave
    Boston, MA 02215

Education & Training

  • University of Southern California/Los Angeles General Medical Center (USC/LA General)
    University of Southern California/Los Angeles General Medical Center (USC/LA General)Fellowship, Adult Cardiothoracic Anesthesiology, 2021 - 2022
  • University of California Davis Health
    University of California Davis HealthResidency, Anesthesiology, 2017 - 2021
  • University of Hawaii, John A. Burns School of Medicine
    University of Hawaii, John A. Burns School of MedicineClass of 2017

Certifications & Licensure

  • CA State Medical License
    CA State Medical License 2018 - 2026
  • MA State Medical License
    MA State Medical License 2024 - 2025
  • American Board of Anesthesiology Anesthesiology
  • American Board of Anesthesiology Adult Cardiac Anesthesiology
  • National Board of EchocardiographyAdvanced PTE

Publications & Presentations

PubMed

Press Mentions

  • Potenzial Von Nichi-Glucan-Nahrungsergänzungsmittel Aus Japan Als Adjuvant Zum COVID-19-Impfstoff
    Potenzial Von Nichi-Glucan-Nahrungsergänzungsmittel Aus Japan Als Adjuvant Zum COVID-19-ImpfstoffMarch 3rd, 2021
  • COVID-19 Vaccine Adjuvant Potentials of Nichi Glucan Dietary Supplement from Japan
    COVID-19 Vaccine Adjuvant Potentials of Nichi Glucan Dietary Supplement from JapanMarch 3rd, 2021
  • Engineering of Human Induced Pluripotent Stem Cells via Human Artificial Chromosome Vectors for Cell Therapy and Disease Modeling
    Engineering of Human Induced Pluripotent Stem Cells via Human Artificial Chromosome Vectors for Cell Therapy and Disease ModelingDecember 19th, 2020